Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases

Benha University50 enrolled

Overview

Suprachoroidal injection is a safe way for intraocular drug delivery. It was used to treat various retinal conditions.

Suprachoroidal triamcinolone acetonide injection is used to treat various retinal diseases, higher concentration of the injected material is found when the suprachoroidal space is used as an intraocular delivery pathway when compared to the conventional intravitreal pathway.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Central Serous Chorioretinopathy Irvine-Gass Syndrome Pars Planitis Cystoid Macular Edema

Interventions

Triamcinolone AcetonideDRUG

Suprachoroidal injection of triamcinolone acetonide

Eligibility

Sex: ALLMin age: 20 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients diagnosed as central serous chorioretinopathy and patients with cystoid macular edema due to irvine-gass syndrome after cataract surgery. Exclusion Criteria: * other retinal diseases that may affect CMT and final visual outcome. * Patients with dense corneal opacity.

Locations (1)

Ahmed Abdelshafy

Banhā, QA, Egypt

RECRUITING

Outcomes

Primary Outcomes

Central macular thickness

Changes in central macular thickness (CMT) measured in millimeters (mm) by optical coherence tomography (OCT)

Time frame: Baseline and 12 months after injection.

Secondary Outcomes

Best corrected visual acuity

Changes in best corrected visual acuity (BCVA) measured in logarithm of minimal angle of resolution (LogMAR) by chart projector.

Time frame: Baseline and 12 months after injection.

Central Contacts

Ahmed Abdelshafy, MD

CONTACT

01222328766 ahmad4lg@gmail.com

Marwa Abdelshafy, MD

CONTACT

01222328766 ahmad4lg@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.